Tag Archives: NASDAQ:CPRX

March, 2017

  • 16 March

    Active Concerns Wondering Movers: Catalyst Pharmaceuticals (NASDAQ:CPRX), Lloyds Banking Group (NYSE:LYG)

    Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) [Trend Analysis] luring active investment momentum, shares an advance 32.48% to $1.55. Catalyst Pharmaceuticals, Inc. (CPRX) reported that positive top-line results from the investigator-sponsored trial evaluating Firdapse (Amifampridine Phosphate) as a treatment for myasthenia gravis patients with anti-MuSK antibodies (MuSK-MG). MuSK-MG, is an ultra-rare sub-population of myasthenia …

December, 2016